Portfolio (Quarterly)
Guide ↗
PSP Research LLC
· CIK 0002106939| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | — | ASCENDIS PHARMA A/S | — | 1,500.0 | $400K | 0.21% | NEW | — | $266.72 | — |
| 2 | LQDA | LIQUIDIA CORPORATION | Healthcare | 5,000.0 | $399K | 0.21% | NEW | — | $79.73 | -15.1% |
| 3 | KRYS | KRYSTAL BIOTECH INC | Healthcare | 692.0 | $257K | 0.14% | NEW | — | $371.67 | -5.4% |
| 4 | AVBP | ARRIVENT BIOPHARMA INC | Healthcare | 7,041.0 | $245K | 0.13% | NEW | — | $34.74 | -13.2% |
| 5 | JAZZ | JAZZ PHARMACEUTICALS PLC | Healthcare | 971.0 | $234K | 0.12% | NEW | — | $240.97 | +1.5% |
| 6 | RVMD | REVOLUTION MEDICINES INC | Healthcare | 1,200.0 | $225K | 0.12% | NEW | — | $187.28 | +11.0% |
| 7 | RYTM | RHYTHM PHARMACEUTICALS INC | Healthcare | 2,000.0 | $222K | 0.12% | NEW | — | $111.03 | -3.5% |
| 8 | DNLI | DENALI THERAPEUTICS INC | Healthcare | 8,463.0 | $218K | 0.12% | NEW | — | $25.72 | -6.7% |
| 9 | ARWR | ARROWHEAD PHARMACEUTICALS IN | Healthcare | 2,600.0 | $212K | 0.11% | NEW | — | $81.51 | +4.2% |
| 10 | SRRK | SCHOLAR ROCK HLDG CORP | Healthcare | 3,827.0 | $210K | 0.11% | NEW | — | $55.00 | +5.1% |
| 11 | CTMX | CYTOMX THERAPEUTICS INC. | Healthcare | 39,400.0 | $148K | 0.08% | NEW | — | $3.75 | -14.4% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%